A charity boss who once tipped the scales at more than 28st says weight-loss injections have changed the way he thinks about ...
While popular drugs like Ozempic and Wegovy are only available as injections, drugmaker Novo Nordisk is working on a more ...
While popular drugs like Ozempic and Wegovy are only available as injections, drugmaker Novo Nordisk is working on a more convenient option: A pill.
Novo Nordisk's CEO is not worried about blockbuster semaglutide drugs being added to Medicare drug pricing negotiations this ...
Ozempic and Wegovy maker Novo Nordisk quieted Wall Street’s concerns with its fourth-quarter results and 2025 outlook.
The drugmaker expects the regulator to remove Wegovy and Ozempic from its shortage list, blocking other companies from ...
New Scientist on MSN17h
New type of brain cell may tell us when to stop eatingBy Chris SimmsNeurons in the brains of mice tell them to stop eating when they’ve had enough food – and since people probably ...
The U.S. Food and Drug Administration ordered a hold on a study of an early-stage obesity drug being developed by Amgen, another potential setback in the company’s efforts to join the booming weight ...
The use of blockbuster weight loss drugs has surged among young women, for whom the treatments can often be "liberating." ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback